Literature DB >> 533880

Fluorinated pyrimidine nucleosides. 3. Synthesis and antitumor activity of a series of 5'-deoxy-5-fluoropyrimidine nucleosides.

A F Cook, M J Holman, M J Kramer, P W Trown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 533880     DOI: 10.1021/jm00197a010

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  19 in total

1.  Potentiation of the chemotherapeutic action of 5'-deoxy-5-fluorouridine in combination with guanosine and related compounds.

Authors:  M Iigo; M Miwa; H Ishitsuka; K Nitta
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  The effect of structural modifications of 5-fluorouracil derivatives on their transport and biodegradation by isolated rat jejunum.

Authors:  L Novotný; H Farghali; I Janků; J Beránek
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Effect of uridine coadministration on 5'-deoxy-5-fluorouridine disposition in rats.

Authors:  J L Au; M G Wientjes; S L Bramer
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Advanced moderately differentiated neuroendocrine carcinoma of the rectum with favorable prognosis by postoperative chemoradiation.

Authors:  Hiroyuki Nojima; Kazuhiro Seike; Chihiro Kosugi; Takashi Shida; Keiji Koda; Kenji Oda; Shigeyuki Kamata; Hiroshi Ishikura; Masaru Miyazaki
Journal:  World J Surg Oncol       Date:  2010-04-17       Impact factor: 2.754

Review 5.  Capecitabine.

Authors:  D R Budman
Journal:  Invest New Drugs       Date:  2000-11       Impact factor: 3.850

6.  Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.

Authors:  Masanori Terashima; Hisataka Fujiwara; Akinori Takagane; Kaoru Abe; Takashi Irinoda; Tsutomu Nakaya; Hitoshi Yonezawa; Kenichi Oyama; Kazuyoshi Saito; Norio Kanzaki; Satoshi Ohtani; Tsuyoshi Nemoto; Yutaka Hoshino; Michihiko Kogure; Mitsukazu Gotoh
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

7.  Effect of coadministered uridine on intestinal first-pass metabolism of 5'-deoxy-5-fluorouridine in conscious rats--an evaluation by method of portal-systemic concentration difference.

Authors:  Y Sawai; K Yamaoka; T Nakagawa
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

8.  Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression levels in tumor and normal tissue specimens of T3 human colorectal carcinoma.

Authors:  Atsushi Okita; Kazunori Tsukuda; Masakazu Murakami; Tetsuya Ota; Hiroyoshi Doihara; Manabu Suda; Tomoharu Nakano; Kinya Matsuoka; Eiji Suzuki; Minoru Naito; Akio Andou; Nobuyoshi Shimizu
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

9.  Doxifluridine combined with weekly paclitaxel for second-line treatment in patients with gastric cancer resistant to TS-1.

Authors:  Wataru Arai; Yoshinori Hosoya; Masanobu Hyodo; Hidenori Haruta; Kentaro Kurashina; Shin Saito; Yuuki Hirashima; Taku Yokoyama; Toru Zuiki; Kazuya Sakuma; Yoshikazu Yasuda; Hideo Nagai
Journal:  Int J Clin Oncol       Date:  2007-04-27       Impact factor: 3.402

10.  Inhibition of intestinal pyrimidine nucleoside phosphorylases.

Authors:  M G Wientjes; J L Au
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.